PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer

PD-1/PD-L1 Correlates With the Efficacy of the Treatment of Concurrent Chemoradiotherapy in Cervical Cancer

BackgroundCervical cancer (CC) is the third most common cancer worldwide, with high mortality rates. The programmed cell death 1 (PD-1)/(PD-1 ligand) PD-L1 has been reported to be an effective indicator in cancer development. In this study, we aim to explore the role of PD-1/PD-L1 in the evaluation...

Full description

Bibliographic Details
Main Authors: Hanqun Zhang, Shisheng Tan, Chunju Fang, Qi Zhang, Xue Cao, Yuncong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
cervical cancer
programmed cell death 1
programmed cell death 1 ligand
concurrent chemoradiotherapy
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.858164/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.858164/full

Similar Items